Model-based approach for predicting the impact of genetic modifications on product yield in biopharmaceutical manufacturing-Application to influenza vaccine production.
A large group of biopharmaceuticals is produced in cell lines. The yield of such products can be increased by genetic engineering of the corresponding cell lines. The prediction of promising genetic modifications by mathematical modeling is a valuable tool to facilitate experimental screening. Besid...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2020-06-01
|
| Series: | PLoS Computational Biology |
| Online Access: | https://doi.org/10.1371/journal.pcbi.1007810 |
| _version_ | 1818582341727027200 |
|---|---|
| author | Stefanie Duvigneau Robert Dürr Tanja Laske Mandy Bachmann Melanie Dostert Achim Kienle |
| author_facet | Stefanie Duvigneau Robert Dürr Tanja Laske Mandy Bachmann Melanie Dostert Achim Kienle |
| author_sort | Stefanie Duvigneau |
| collection | DOAJ |
| description | A large group of biopharmaceuticals is produced in cell lines. The yield of such products can be increased by genetic engineering of the corresponding cell lines. The prediction of promising genetic modifications by mathematical modeling is a valuable tool to facilitate experimental screening. Besides information on the intracellular kinetics and genetic modifications the mathematical model has to account for ubiquitous cell-to-cell variability. In this contribution, we establish a novel model-based methodology for influenza vaccine production in cell lines with overexpressed genes. The manipulation of the expression level of genes coding for host cell factors relevant for virus replication is achieved by lentiviral transduction. Since lentiviral transduction causes increased cell-to-cell variability due to different copy numbers and integration sites of the gene constructs we use a population balance modeling approach to account for this heterogeneity in terms of intracellular viral components and distributed kinetic parameters. The latter are estimated from experimental data of intracellular viral RNA levels and virus titers of infection experiments using cells overexpressing a single host cell gene. For experiments with cells overexpressing multiple host cell genes, only final virus titers were measured and thus, no direct estimation of the parameter distributions was possible. Instead, we evaluate four different computational strategies to infer these from single gene parameter sets. Finally, the best computational strategy is used to predict the most promising candidates for future modifications that show the highest potential for an increased virus yield in a combinatorial study. As expected, there is a trend to higher yields the more modifications are included. |
| first_indexed | 2024-12-16T07:47:51Z |
| format | Article |
| id | doaj.art-a1dd109314ad406dbfc097aaa44f7eef |
| institution | Directory Open Access Journal |
| issn | 1553-734X 1553-7358 |
| language | English |
| last_indexed | 2024-12-16T07:47:51Z |
| publishDate | 2020-06-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS Computational Biology |
| spelling | doaj.art-a1dd109314ad406dbfc097aaa44f7eef2022-12-21T22:38:56ZengPublic Library of Science (PLoS)PLoS Computational Biology1553-734X1553-73582020-06-01166e100781010.1371/journal.pcbi.1007810Model-based approach for predicting the impact of genetic modifications on product yield in biopharmaceutical manufacturing-Application to influenza vaccine production.Stefanie DuvigneauRobert DürrTanja LaskeMandy BachmannMelanie DostertAchim KienleA large group of biopharmaceuticals is produced in cell lines. The yield of such products can be increased by genetic engineering of the corresponding cell lines. The prediction of promising genetic modifications by mathematical modeling is a valuable tool to facilitate experimental screening. Besides information on the intracellular kinetics and genetic modifications the mathematical model has to account for ubiquitous cell-to-cell variability. In this contribution, we establish a novel model-based methodology for influenza vaccine production in cell lines with overexpressed genes. The manipulation of the expression level of genes coding for host cell factors relevant for virus replication is achieved by lentiviral transduction. Since lentiviral transduction causes increased cell-to-cell variability due to different copy numbers and integration sites of the gene constructs we use a population balance modeling approach to account for this heterogeneity in terms of intracellular viral components and distributed kinetic parameters. The latter are estimated from experimental data of intracellular viral RNA levels and virus titers of infection experiments using cells overexpressing a single host cell gene. For experiments with cells overexpressing multiple host cell genes, only final virus titers were measured and thus, no direct estimation of the parameter distributions was possible. Instead, we evaluate four different computational strategies to infer these from single gene parameter sets. Finally, the best computational strategy is used to predict the most promising candidates for future modifications that show the highest potential for an increased virus yield in a combinatorial study. As expected, there is a trend to higher yields the more modifications are included.https://doi.org/10.1371/journal.pcbi.1007810 |
| spellingShingle | Stefanie Duvigneau Robert Dürr Tanja Laske Mandy Bachmann Melanie Dostert Achim Kienle Model-based approach for predicting the impact of genetic modifications on product yield in biopharmaceutical manufacturing-Application to influenza vaccine production. PLoS Computational Biology |
| title | Model-based approach for predicting the impact of genetic modifications on product yield in biopharmaceutical manufacturing-Application to influenza vaccine production. |
| title_full | Model-based approach for predicting the impact of genetic modifications on product yield in biopharmaceutical manufacturing-Application to influenza vaccine production. |
| title_fullStr | Model-based approach for predicting the impact of genetic modifications on product yield in biopharmaceutical manufacturing-Application to influenza vaccine production. |
| title_full_unstemmed | Model-based approach for predicting the impact of genetic modifications on product yield in biopharmaceutical manufacturing-Application to influenza vaccine production. |
| title_short | Model-based approach for predicting the impact of genetic modifications on product yield in biopharmaceutical manufacturing-Application to influenza vaccine production. |
| title_sort | model based approach for predicting the impact of genetic modifications on product yield in biopharmaceutical manufacturing application to influenza vaccine production |
| url | https://doi.org/10.1371/journal.pcbi.1007810 |
| work_keys_str_mv | AT stefanieduvigneau modelbasedapproachforpredictingtheimpactofgeneticmodificationsonproductyieldinbiopharmaceuticalmanufacturingapplicationtoinfluenzavaccineproduction AT robertdurr modelbasedapproachforpredictingtheimpactofgeneticmodificationsonproductyieldinbiopharmaceuticalmanufacturingapplicationtoinfluenzavaccineproduction AT tanjalaske modelbasedapproachforpredictingtheimpactofgeneticmodificationsonproductyieldinbiopharmaceuticalmanufacturingapplicationtoinfluenzavaccineproduction AT mandybachmann modelbasedapproachforpredictingtheimpactofgeneticmodificationsonproductyieldinbiopharmaceuticalmanufacturingapplicationtoinfluenzavaccineproduction AT melaniedostert modelbasedapproachforpredictingtheimpactofgeneticmodificationsonproductyieldinbiopharmaceuticalmanufacturingapplicationtoinfluenzavaccineproduction AT achimkienle modelbasedapproachforpredictingtheimpactofgeneticmodificationsonproductyieldinbiopharmaceuticalmanufacturingapplicationtoinfluenzavaccineproduction |